Related Experiment Video
Updated: Nov 7, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
João Diogo Dias1, Nazim Sarica1, Christine Neuveut1
1Laboratoire de Virologie Moléculaire, Institut de Génétique Humaine, CNRS, Université de Montpellier, UMR9002 Montpellier, France.
Insights
Hepatitis B virus (HBV) infection persists due to viral covalently closed circular DNA (cccDNA) resisting treatments. Understanding cccDNA formation is key to eradicating HBV.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus (HBV) infection affects over 250 million people globally.
- Chronic HBV infection increases the risk of liver cirrhosis and hepatocellular carcinoma.
- Current antiviral therapies control HBV replication but do not eliminate the virus due to persistent viral DNA.
Purpose of the Study:
- To review the current understanding of HBV infection's initial steps.
- To focus on the formation and role of covalently closed circular DNA (cccDNA).
- To highlight cccDNA as a critical target for HBV eradication strategies.
Main Methods:
- Review of existing literature on HBV nuclear import and cccDNA formation.
- Analysis of the molecular mechanisms governing HBV replication intermediates.
- Synthesis of data on cccDNA's role in viral persistence and transcription.
Main Results:
- Viral persistence is primarily attributed to the stable episomal HBV DNA, cccDNA.
- cccDNA resides in the nucleus, evades immune surveillance, and resists antiviral therapies.
- cccDNA serves as the template for all viral RNA transcription, including pgRNA, perpetuating infection.
Conclusions:
- The establishment and expression of cccDNA are central to HBV persistence.
- Targeting the formation or expression of cccDNA is crucial for developing curative HBV therapies.
- Further research into the early stages of HBV infection, particularly cccDNA dynamics, is essential for achieving viral eradication.
Abstract:
Hepatitis B virus (HBV) remains a major public health concern, with more than 250 million chronically infected people who are at high risk of developing liver diseases, including cirrhosis and hepatocellular carcinoma. Although antiviral treatments efficiently control virus replication and improve liver function, they cannot cure HBV infection. Viral persistence is due to the maintenance of the viral circular episomal DNA, called covalently closed circular DNA (cccDNA), in the nuclei of infected cells. cccDNA not only resists antiviral therapies, but also escapes innate antiviral surveillance. This viral DNA intermediate plays a central role in HBV replication, as cccDNA is the template for the transcription of all viral RNAs, including pregenomic RNA (pgRNA), which in turn feeds the formation of cccDNA through a step of reverse transcription. The establishment and/or expression of cccDNA is thus a prime target for the eradication of HBV. In this review, we provide an update on the current knowledge on the initial steps of HBV infection, from the nuclear import of the nucleocapsid to the formation of the cccDNA.
More Related Videos
11:14Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
What are Viruses?
Lytic Cycle of Bacteriophages
Size and Structure of Viral Genomes
Viral Replication: Lytic Cycle